2CLisaB

2CLisaB
Clinical data
Drug classSerotonin receptor modulator
ATC code
  • None
Identifiers
  • 2-[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline
Chemical and physical data
FormulaC19H22BrNO2
Molar mass376.294 g·mol−1
3D model (JSmol)
  • COc1cc(Br)c(cc1CCN1CCc2c(C1)cccc2)OC
  • InChI=1S/C19H22BrNO2/c1-22-18-12-17(20)19(23-2)11-15(18)8-10-21-9-7-14-5-3-4-6-16(14)13-21/h3-6,11-12H,7-10,13H2,1-2H3
  • Key:FUQOBJZWVZVGDO-UHFFFAOYSA-N

2CLisaB, also known as 2-[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline, is a serotonin receptor modulator of the phenethylamine, 2C, and 25-NB families. It is a cyclized phenethylamine analogue of the serotonergic psychedelic 25B-NBOMe in which the N-benzyl group has been cyclized with the amine to form a tetrahydroisoquinoline ring. The drug shows affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 45–1,580 nM and 270–77,680 nM, respectively). 2CLisaB was first described in the scientific literature by Michael Robert Braden of the lab of David E. Nichols at Purdue University in 2007.

The compound without the 4-bromo substitution is known as 2CLisaH. It shows much lower affinities for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 690–1,158 nM and 1,303–1,404 nM, respectively).

See also